Ongoing outbreak of human adenovirus-associated acute respiratory illness in the Republic of Korea military, 2013 to 2018
1
조회
0
다운로드
2
인용
0
참고문헌
키워드
초록
Background/Aims: Human adenovirus type 55 (HAdV-55), an emerging epidemic strain, has caused several large outbreaks in the Korean military since 2014, and HAdV-associated acute respiratory illness (HAdV-ARI) has been continuously reported thereafter. Methods: To evaluate the epidemiologic characteristics of HAdV-ARI in the Korean military, we analyzed respiratory virus polymerase chain reaction (RV-PCR) results, pneumonia surveillance results, and severe HAdV cases from all 14 Korean military hospitals from January 2013 to May 2018 and compared these data with nationwide RV surveillance data for the civilian population. Results: A total of 14,630 RV-PCRs was performed at military hospitals. HAdV (45.4%) was the most frequently detected RV, followed by human rhinovirus (12.3%) and influenza virus (6.3%). The percentage of the military positive for HAdV was significantly greater than the percentage of civilians positive for HAdV throughout the study period, with a large outbreak occurring during the winter to spring of 2014 to 2015. The outbreak continued until the end of the study, and non-seasonal detections increased over time. The reported number of pneumonia patients also increased during the outbreak. Case fatality rate was 0.075% overall but 15.6% in patients with respiratory failure. The proportion of severe patients did not change significantly during the study period. Conclusions: A large HAdV outbreak is currently ongoing in the Korean military, with a trend away from seasonality, and HAdV-55 is likely the predominant strain. Persistent efforts to control the outbreak, HAdV type-specific surveillance, and vaccine development are required.
Abstract
Background/Aims: Human adenovirus type 55 (HAdV-55), an emerging epidemic strain, has caused several large outbreaks in the Korean military since 2014, and HAdV-associated acute respiratory illness (HAdV-ARI) has been continuously reported thereafter. Methods: To evaluate the epidemiologic characteristics of HAdV-ARI in the Korean military, we analyzed respiratory virus polymerase chain reaction (RV-PCR) results, pneumonia surveillance results, and severe HAdV cases from all 14 Korean military hospitals from January 2013 to May 2018 and compared these data with nationwide RV surveillance data for the civilian population. Results: A total of 14,630 RV-PCRs was performed at military hospitals. HAdV (45.4%) was the most frequently detected RV, followed by human rhinovirus (12.3%) and influenza virus (6.3%). The percentage of the military positive for HAdV was significantly greater than the percentage of civilians positive for HAdV throughout the study period, with a large outbreak occurring during the winter to spring of 2014 to 2015. The outbreak continued until the end of the study, and non-seasonal detections increased over time. The reported number of pneumonia patients also increased during the outbreak. Case fatality rate was 0.075% overall but 15.6% in patients with respiratory failure. The proportion of severe patients did not change significantly during the study period. Conclusions: A large HAdV outbreak is currently ongoing in the Korean military, with a trend away from seasonality, and HAdV-55 is likely the predominant strain. Persistent efforts to control the outbreak, HAdV type-specific surveillance, and vaccine development are required.
참고문헌 (38)
- Kim JM, "Nation-wide surveillance of human acute respiratory virus infections between 2013 and 2015 in Korea", J Med Virol, 90, pp.1177~1183 (2018)
- Hakim FA, "Severe adenovirus pneumonia in immunocompetent adults : a case report and review of the literature", Eur J Clin Microbiol Infect Dis, 27, pp.153~158 (2008)
- Klinger JR, "Multiple cases of life-threatening adenovirus pneumonia in a mental health care center", Am J Respir Crit Care Med, 157, pp.645~649 (1998)
- Ryan MA, "Large epidemic of respiratory illness due to adenovirus types 7 and 3 in healthy young adults", Clin Infect Dis, 34, pp.577~582 (2002)
- Top FH Jr, "Control of respiratory disease in recruits with types 4 and 7adenovirus vaccines", Am J Epidemiol, 94, pp.142~146 (1971)
- Chmielewicz B, "Respiratory disease caused by a species B2 adenovirus in a military camp in Turkey", J Med Virol, 77, pp.232~237 (2005)
- Hierholzer JC, "Occurrence of respiratory illness due to an atypical strain of adenovirus type 11 during a large outbreak in Spanish military recruits", Am J Epidemiol, 99, pp.434~442 (1974)
- Zhu Z, "Outbreak of acute respiratory disease in China caused by B2 species of adenovirus type11", J Clin Microbiol, 47, pp.697~703 (2009)
- Walsh MP, "Computational analysis identifies human adenovirus type 55 as a re-emergent acute respiratory disease pathogen", J Clin Microbiol, 48, pp.991~993 (2010)
- Kajon AE, "Outbreak of febrile respiratory illness associated with adenovirus 11a infection in a Singapore military training cAMP", J Clin Microbiol, 48, pp.1438~1441 (2010)
- Cao B, "Emergence of community-acquired adenovirus type 55 as a cause of community-onset pneumonia", Chest, 145, pp.79~86 (2014)
- Lu QB, "Epidemiology of human adenovirus and molecular characterization of human adenovirus 55 in China, 2009-2012", Influenza Other Respir Viruses, 8, pp.302~308 (2014)
- Sun B, "Emergent severe acute respiratory distress syndrome caused by adenovirus type 55 in immunocompetent adults in 2013 : a prospective observational study", Crit Care, 18, pp.456~ (2014)
- Gao HW, "Dynamic changes in clinical characteristics during an outbreak of human adenovirus serotype 55 in China", Disaster Med Public Health Prep, 12, pp.464~469 (2018)
- Lafolie J, "Severe pneumonia associated with adenovirus type 55 infection, France, 2014", Emerg Infect Dis, 22, pp.2012~2014 (2016)
- Salama M, "Outbreak of adenovirus type 55 infection in Israel", J Clin Virol, 78, pp.31~35 (2016)
- Wang W, "Whole-genome analyses of human adenovirus type 55 emerged in Tibet, Sichuan and Yunnan in China, in 2016", PLoS One, 12, pp.e0189625~ (2017)
- Zheng X, "Seroprevalence of neutralizing antibodies against adenovirus type 14 and 55 in healthy adults in Southern China", Emerg Microbes Infect, 6, pp.e43~ (2017)
- Kim SJ, "Outcomes of early administration of cidofovir in non-immunocompromised patients with severe adenovirus pneumonia", PLoS One, 10, pp.e0122642~ (2015)
- Yoo H, "Febrile respiratory illness associated with human adenovirus type 55 in South Korea military, 2014-2016", Emerg Infect Dis, 23, pp.1016~1020 (2017)
- Hwang SM, "Outbreak of febrile respiratory illness caused by adenovirus at a South Korean military training facility : clinical and radiological characteristics of adenovirus pneumonia", Jpn J Infect Dis, 66, pp.359~365 (2013)
- Park JY, "Clinical features and courses of adenovirus pneumonia in healthy young adults during an outbreak among Korean military personnel", PLoS One, 12, pp.e0170592~ (2017)
- Heo JY, "Molecular epidemiology of human adenovirus-associated febrile respiratory illness in soldiers, South Korea", Emerg Infect Dis, 24, pp.1221~1227 (2018)
- Kim HS, "The usefulness of hand washing during field training to prevent acute respiratory illness in a military training facility", Medicine(Baltimore), 97, pp.e11594~ (2018)
- Heo JY, "Acute lower respiratory tract infections in soldiers, South Korea, April 2011-March 2012", Emerg Infect Dis, 20, pp.875~877 (2014)
- Jeon K, "High isolation rate of adenovirus serotype 7 from South Korean military recruits with mild acute respiratory disease", Eur J Clin Microbiol Infect Dis, 26, pp.481~483 (2007)
- Lee J, "Clinical severity of respiratory adenoviral infection by serotypes in Korean children over 17consecutive years(1991-2007)", J Clin Virol, 49, pp.115~120 (2010)
- 허중연, "한국 군인에서 중증 아데노바이러스 폐렴의 임상 양상", Infection and Chemotherapy, 44(5), pp.372~376 (2012), 대한감염학회
- Chen WW, "Cross-sectional study of the relationship of peripheral blood cell profiles with severity of infection by adenovirus type 55", BMC Infect Dis, 14, pp.147~ (2014)
- Gu L, "Severe community-acquired pneumonia caused by adenovirus type 11 in immunocompetent adults in Beijing", J Clin Virol, 54, pp.295~301 (2012)
- Ko JH, "Predictive factors for pneumonia development and progression to respiratory failure in MERS-CoV infected patients", J Infect, 73, pp.468~475 (2016)
- Park GE, "Control of an outbreak of Middle East respiratory syndrome in a tertiary hospital in Korea", Ann Intern Med, 165, pp.87~93 (2016)
- 최원석, "Clinical Presentation and Outcomes of Middle East Respiratory Syndrome in the Republic of Korea", Infection and Chemotherapy, 48(2), pp.118~126 (2016), 대한감염학회
- Barker JH, "Fatal type 3 adenoviral pneumonia in immunocompetent adult identical twins", Clin Infect Dis, 37, pp.e142~e146 (2003)
- Hoke CH Jr, "History of the restoration of adenovirus type 4 and type 7 vaccine, live oral(adenovirus vaccine)in the context of the department of defense acquisition system", Vaccine, 31, pp.1623~1632 (2013)
- Liu T, "A recombinant trivalent vaccine candidate against human adenovirus types 3, 7, and 55", Vaccine, 36, pp.2199~2206 (2018)
- Feng Y, "Hexon and fiber of adenovirus type 14 and 55 are major targets of neutralizing antibody but only fiber-specific antibody contributes to cross-neutralizing activity", Virology, 518, pp.272~283 (2018)
- Tian X, "A tetravalent vaccine comprising hexon-chimeric adenoviruses elicits balanced protective immunity against human adenovirus types 3, 7, 14 and 55", Antiviral Res, 154, pp.17~25 (2018)